Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedJun 14, 2026
DataAggregated Company Financials
Companies20
  • 7D0.8%
  • 3M12.0%
  • 1Y-38.9%
  • YTD-13.3%

In the last week, the Healthcare industry is flat overall, with Zealand Pharma standing out by going down 9.3%. As for the longer term, the industry has declined 39% in the last year. As for the next few years, earnings are expected to grow by 3.0% per annum.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 14 Jun 2026DKK 1.7tDKK 468.8bDKK 147.1b19.7x11.5x3.6x
Tue, 12 May 2026DKK 1.7tDKK 467.5bDKK 148.5b21.1x11.8x3.7x
Thu, 09 Apr 2026DKK 1.5tDKK 447.4bDKK 130.0b17.8x11.4x3.3x
Sat, 07 Mar 2026DKK 1.5tDKK 448.2bDKK 131.1b17.1x11.6x3.4x
Mon, 02 Feb 2026DKK 2.1tDKK 453.5bDKK 136.8b17.6x15.5x4.7x
Wed, 31 Dec 2025DKK 1.9tDKK 453.7bDKK 136.8b17.2x14.2x4.3x
Fri, 28 Nov 2025DKK 1.9tDKK 454.1bDKK 137.0b17.5x13.8x4.2x
Sun, 26 Oct 2025DKK 2.0tDKK 447.8bDKK 141.8b18.7x14.3x4.5x
Tue, 23 Sep 2025DKK 2.2tDKK 447.2bDKK 141.6b18.9x15.5x4.9x
Thu, 21 Aug 2025DKK 2.0tDKK 444.6bDKK 139.8b29.5x14.4x4.5x
Sat, 19 Jul 2025DKK 2.3tDKK 423.3bDKK 124.5b29.9x18.4x5.4x
Mon, 16 Jun 2025DKK 2.8tDKK 423.4bDKK 124.6b31.4x22.3x6.5x
Wed, 14 May 2025DKK 2.4tDKK 423.4bDKK 124.9b23x19.1x5.6x
Fri, 11 Apr 2025DKK 2.3tDKK 409.3bDKK 121.3b21.2x18.6x5.5x
Sun, 09 Mar 2025DKK 3.2tDKK 409.5bDKK 121.3b27x26.1x7.7x
Tue, 04 Feb 2025DKK 3.3tDKK 387.8bDKK 111.4b28.2x29.2x8.4x
Thu, 02 Jan 2025DKK 3.3tDKK 387.4bDKK 111.3b29.9x29.6x8.5x
Sat, 30 Nov 2024DKK 3.9tDKK 387.3bDKK 111.3b31.2x35.2x10.1x
Mon, 28 Oct 2024DKK 4.1tDKK 372.2bDKK 107.2b34x37.9x10.9x
Wed, 25 Sep 2024DKK 4.3tDKK 371.9bDKK 107.1b37x40.1x11.5x
Fri, 23 Aug 2024DKK 4.7tDKK 371.9bDKK 107.1b36.3x43.9x12.6x
Sun, 21 Jul 2024DKK 4.6tDKK 355.3bDKK 106.2b35.6x43.3x12.9x
Tue, 18 Jun 2024DKK 4.9tDKK 355.3bDKK 106.2b35.7x46.2x13.8x
Thu, 16 May 2024DKK 4.7tDKK 355.4bDKK 106.6b35.3x43.8x13.1x
Sat, 13 Apr 2024DKK 4.5tDKK 341.3bDKK 99.7b33.5x45.1x13.2x
Mon, 11 Mar 2024DKK 4.7tDKK 341.2bDKK 99.6b39.6x46.7x13.6x
Wed, 07 Feb 2024DKK 4.2tDKK 338.6bDKK 98.5b34.8x42.3x12.3x
Fri, 05 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b33.1x41.9x11.8x
Sun, 03 Dec 2023DKK 3.6tDKK 320.5bDKK 90.0b32.8x40.3x11.3x
Tue, 31 Oct 2023DKK 3.5tDKK 305.6bDKK 82.3b26.5x42.5x11.4x
Thu, 28 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b32.9x41.5x11.2x
Sat, 26 Aug 2023DKK 3.4tDKK 305.2bDKK 82.1b35.4x41.2x11.1x
Mon, 24 Jul 2023DKK 3.0tDKK 287.0bDKK 75.4b40.6x40.1x10.6x
Wed, 21 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40x39.7x10.4x
Price to Earnings Ratio

39.7x


Total Market Cap: DKK 3.0tTotal Earnings: DKK 75.5bTotal Revenue: DKK 287.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 29.7x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.5x which is lower than its 3-year average PE of 29.7x.
  • The 3-year average PS ratio of 8.6x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market0.78%
Healthcare0.81%
Healthtech3.44%
Pharma1.10%
Life Sciences0.40%
Biotech0.07%
Medical Equipment-0.88%
Healthcare Services-3.08%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 33.1x.
    • Analysts are expecting annual earnings growth of 20.1%, which is higher than its past year's earnings growth of 0.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 113% over the next 5 years.
  • In contrast, the Life Sciences industry is expected to see its earnings decline by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 287.251.2%
+DKK 15.1b		-44.4%PE10.4x
GMAB GenmabDKK 1.62k2.2%
+DKK 2.2b		9.3%PE18.7x
ALK B ALK-AbellóDKK 270.401.6%
+DKK 930.6m		45.8%PE46.8x
BAVA Bavarian NordicDKK 184.100.8%
+DKK 114.7m		0.1%PE12x
GUBRA GubraDKK 361.401.7%
+DKK 101.3m		-33.4%PE3.5x

Latest News

NOVO B
DKK 287.25
Novo Nordisk
7D
1.2%
1Y
-44.4%
GUBRA
DKK 361.40
Gubra
7D
1.7%
1Y
-33.4%
ZEAL
DKK 295.80
Zealand Pharma
7D
-9.3%
1Y
-34.5%
GMAB
DKK 1,619.00
Genmab
7D
2.2%
1Y
9.3%
ALK B
DKK 270.40
ALK-Abelló
7D
1.6%
1Y
45.8%
Narrative Update • Jun 12

ALK B: Future Returns Will Reflect Allergy Immunotherapy And Anaphylaxis Treatment Progress

Narrative Update on ALK-Abelló The analyst price target for ALK-Abelló has been updated to DKK 305, with analysts pointing to the company’s position as a global market leader in allergy immunotherapy as a key factor in this valuation. What's in the News At the 2026 EAACI Congress, ALK presented data on real world anaphylaxis management, highlighting frequent gaps in adrenaline auto injector use.
DEMANT
DKK 251.20
Demant
7D
-0.4%
1Y
-10.8%
BAVA
DKK 184.10
Bavarian Nordic
7D
0.8%
1Y
0.1%
HLUN B
DKK 43.70
H. Lundbeck
7D
-2.5%
1Y
11.5%
Narrative Update • Jun 06

HLUN B: Softer Revenue Outlook Will Weigh On Future Earnings Multiple

Analysts now keep their DKK 34.00 price target for H. Lundbeck unchanged, citing a slightly higher assumed discount rate, softer revenue growth, and firmer profit margin and future P/E expectations in their models.
EMBLA
DKK 26.70
Embla Medical hf
7D
-2.7%
1Y
-21.9%
Narrative Update • Jun 06

EMBLA: Ongoing Buybacks And Share Cancellations Will Support Future Upside

Analysts have kept their DKK price target for Embla Medical hf. broadly unchanged, with only a marginal adjustment driven by a slightly lower discount rate and a small tweak to the assumed future P/E multiple.
COLO B
DKK 382.90
Coloplast
7D
-0.2%
1Y
-39.9%
AMBU B
DKK 63.10
Ambu
7D
-4.4%
1Y
-35.0%
Narrative Update • Jun 03

AMBU B: Bearish Street Sentiment Will Support Future Upside Repricing

Analysts have reduced their price target on Ambu to DKK 88.8, citing a more cautious stance reflected in recent bearish Street research and downgrades. What's in the News Analysts have adopted a more cautious stance on Ambu, reflected in recent bearish research and rating downgrades from the Street.
MONSO
DKK 0.29
Monsenso
7D
23.9%
1Y
4.3%
BIOPOR
DKK 1.18
BioPorto
7D
-8.9%
1Y
-15.0%
NNIT
DKK 41.45
NNIT
7D
3.0%
1Y
-41.5%
CHEMM
DKK 374.60
ChemoMetec
7D
-0.8%
1Y
-29.5%
STENO
DKK 1.09
Stenocare
7D
2.8%
1Y
73.6%